2025. Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study. Student’s Journal of Health Research Africa. 6, 12 (Dec. 2025), 8. DOI:https://doi.org/10.51168/sjhrafrica.v7i3.2192.